GSA Capital Partners »

Arcutis Biotherapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $242k 75k 3.23
2022-03-31 $536k 28k 19.25

More positions owned by GSA Capital Partners

Amazon (AMZN)
CRH Ord (CRH)
Remitly Global (RELY)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Aon Shs Cl A (AON)
Magnite Ord (MGNI)
Zillow Group Cl A (ZG)
UnitedHealth (UNH)
Sprott Fds Tr Uranium Miners E (URNM)
Vanguard World Fds Health Car Etf (VHT)
Sba Communications Corp Cl A (SBAC)
Calavo Growers (CVGW)
Appfolio Com Cl A (APPF)
Star Bulk Carriers Corp. Shs Par (SBLK)
Bwx Technologies (BWXT)

View all positions for GSA Capital Partners

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Frazier Life Sciences Management
Vanguard Group
Franklin Resources
Millennium Management
Opaleye Management
Jennifer Ranahan
Deutsche Bank Aktiengesellschaft
Tejara Capital
Two Sigma Investments
Goldman Sachs Group
Charles Schwab Investment Management
Federated Investors
AMI Asset Management Corporation
Walleye Trading Advisors

View all funds holding Arcutis Biotherapeutics